Press Releases

BeiGene to Attend 2013 DIA

May 12, 2013 at 9:21 PM EDT

BEIGENE announced today John Gong, Vice President of Drug Development and Regulatory Affairs of BeiGene will attend 2013 DIA from May 12-15 in Beijing International Convention Center, China.

For further information, please contact: pr@beigene.com.

About BeiGene
BeiGene is a Chinese life sciences biotechnology company based in the Zhongguancun Life Science Park in Beijing that is focused on discovering and developing innovative oncology drugs that encompass novel small molecules and biologics. BeiGene is pursuing this through its own internal discovery laboratories in China and by in-licensing from pharmaceutical partners investigational therapeutics that address unmet medical needs for Chinese and Asian patients with cancer. BeiGene is also creating a robust biomarkers and bioinformatics platform to enable the identification of specific subsets of patient populations who will most likely benefit from the use of specific drugs or treatments.

For more information, please visit www.beigene.com.